Table: RaQualia Pharma -2020 group forecast
Dec 28 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2020 Dec 31, 2020
LATEST PREVIOUS
FORECAST FORECAST
Sales 852 mln 1.58
Operating loss 753 mln loss 260 mln
Recurring loss 759 mln loss 256 mln
Net loss 843 mln loss 333 mln
EPS loss 40.24 yen loss 15.93 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T